Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features

Clinical Cancer Research

Volumn 2, Issue 11, 1996, Pages 1873-1878

  Heffelfinger, Sue C ^a   Yassin, Rawia ^a   Miller, Mary Ann ^a   Lower, Elyse ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; CANCER RISK; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 0029806032     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wellings, S. R., Jensen, H. M., and Marcum, R. G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst., 55: 231-273, 1975.
2. Page, D. L., Zwaag, R. S., Rogers, L. W., Williams, L. T., Walker, W. E., and Hartmann, W. H. Relation between component parts of fibrocystic disease complex and breast cancer. J. Natl. Cancer Inst., 61: 1055-1063, 1978.
3. Bodian, C. A., Perzin, K. H., Lattes, R., Hoffmann, P., and Abernathy, T. G. Prognostic significance of benign proliferative breast disease. Cancer (Phila.), 71: 3896-3907, 1993.
4. Page, D. L., and Dupont, W. D. Benign breast disease: indicators of increased breast cancer risk. Cancer Detect. Prev., 16: 93-97, 1992.
5. Ernster, V. L., Barclay, J., Kerlikowske, K., Grady, D., and Henderson, C. Incidence of and treatment for ductal carcinoma in situ of the breast. J. Am. Med. Assoc., 275. 913-918, 1996.
6. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
7. Weidner, N, Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N. Engl. J. Med., 324: 1-8, 1991.
8. Horak, E. R., Leek, R , Klenk, N., LeJeune, S., Smith, K., Stuart, N., Greenall, M , Stepniewska, K., and Harris, A L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastases and survival in breast cancer. Lancet, 340: 1120-1124, 1992.
9. Bosari, S., Lee, A. K. C , DeLellis, R. A., Wiley, B. D , Heatley, G. J., and Silverman, M. L. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol., 23: 755-761, 1992.
10. Toi, M., Kasitani, J., and Tominaga, T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer, 55: 371-374, 1993.
11. Visscher, D. W., Smilanetz, S., Drozdowicz, S , and Wykes, S. M. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma Anal. Quant. Cytol. Histol., 15: 88-92, 1993.
12. Fox, S. B., Leek, R. D. Smith, K , Hollyer, J., Greenall, M , and Harris, A. L. Tumor angiogenesis in node-negative breast carcinomas: relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res. Treat., 29: 109-116, 1994
13. Obermair, A., Czerwenda, K., Kurz, C., Kaider, A., and Sevelda, P Influence of tumoral microvessel density on the recurrence-free survival in human breast cancer: preliminary results. Onkologie, 17: 44-49, 1994
14. Gasparini, G., Weidner, N., Bevilacqua, P., Maluta, S., Dalla Palma, P., Caffo, O., Barbareschi, M., Boracchi, P., Marubini, E., and Pozza, F. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol., 12: 454-466, 1994.
15. Toi, M., Inada, K., Suzuki, H., and Tommaga, T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat., 36: 193-204, 1995.
16. Folkman, J., Watson, K., Ingber, D., and Hanahan, D Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
17. Gimbrone, M. A., and Gullino, P. M. Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues. J. Natl. Cancer Inst., 56: 305-318, 1976.
18. Brem, S. S., Gullino, P. M., and Medina, D. Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science (Washington DC), 195: 880-881, 1977
19. Ottinetti, A., and Sapino, A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions Breast Cancer Res. Treat., 11: 241-248, 1988.
20. Guinebretiere, J. M., Monique, G. L., Gavoille, A., Bahi, J., and Contesso, G. Angiogenesis and risk of breast cancer in women with fibrocystic disease. J. Natl. Cancer Inst., 86: 35-36, 1994.
21. Fox, S. B., Gatter, K. C., Bicknell, R., Going, J. J., Stanton, P., Cooke, T. G., and Hams, A. L. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res., 53: 4161-4163, 1993.
22. Vartanian, R K., and Weidner, N. Correlation in intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am. J. Pathol., 144: 1188-1194, 1994.
23. Fregene, T. A., Kellogg, C. M., and Pienta, K. J. Microvessel quantification as a measure of angiogenic activity in benign breast tissue lesions: a marker for precancerous disease? Int. J. Oncol., 4: 1199-1202, 1994.
24. Guidi, A. J., Fischer, L., Hams, J. R., and Schnitt, S. J. Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl Cancer Inst., 86: 614-619, 1994.
25. Hutter, R. V. P. Consensus meeting: is "fibrocystic disease" of the breast precancerous? Arch Pathol. Lab. Med., 110: 171-173, 1985.
26. Jensen, R. A., DuPont, W. D., and Page, D. L. Diagnostic criteria and cancer risk of proliferative breast lesion. J. Cell. Biochem. Suppl., 17G: 59-64, 1993.
27. Page, D., and Anderson, T. Diagnostic Histopathology of the Breast. Edinburgh, Scotland: Churchill Livingstone, 1987.
28. Silverstein, M. J., Lagios, M. D., Craig, P. H., Waisman, J. R., Lewinsky, B. S., Colburn, W. J., and Poller, D. N. A prognostic index for ductal carcinoma in situ of the breast. Cancer (Phila.), 77: 2267-2274, 1996.
29. Holland, R., Peterse, J. L., Millis, R. R., Eusebi, V., Faverly, D , van de Vijver, M. J., and Zafrani, B. Ductal carcinoma in situ: a proposal for a new classification. Semin. Diag. Pathol., 11: 167-180, 1994.
30. Bloom, H. J. G., and Richardson, W W. Histologic grading and prognosis in breast cancer. Br. J. Cancer, 11: 359-377, 1957.
31. Glantz, S. A. Primer of Biostatistics, 3rd ed., Chap. 10, pp. 320-371. New York: McGraw Hill, Inc. 1981.
32. Levi, F, Randimbison, L., and La Vecchia, C. Breast cancer survival in relation to sex and age. Oncology, 49: 413-417, 1992.
33. Gasparini, G., and Harris, A. L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma, much more than a new prognostic tool. J. Clin. Oncol., 13: 765-782, 1995.
34. Jensen, H. M., Chen, I., DeVault, M. R., and Lewis, A. E. Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. Science (Washington DC), 218: 293-294, 1982.
35. V mice exhibit a decreased rate of tumor angiogenesis. Int. J. Cancer, 42: 48-52, 1988
36. Contrino, J., Hair, G., Kreutzer, K. L., and Rickles, F. R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease Nat. Med., 2: 209-215, 1996.
37. Brooks, P C., Stromblad, S., Klemde, R., Visscher, D., Sarkar, F. H., and Cheresh, D. A Antiintegrin αVβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest., 96. 1815-1822, 1995.
38. Patey, N., Vazeux, R., Canioni, D., Potter, T., Gallatin, W. M., and Brousse, N. Intercellular adhesion molecule-3 on endothelial cells: expression in tumors but not in inflammatory responses. Am. J. Pathol., 148: 465-472, 1996.
39. Wernert, N., Raes, M B., Lassalle, P., Dehouch, M P., Gosselin, B., Vandenbunder, B , and Stehelin, D. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol., 140: 119-127, 1992.